Development Bank of Wales Invests £350,000 in Amped PCR to Revolutionise DNA Testing

The Development Bank of Wales has invested £350,000 in Amped PCR, a pioneering DNA-tech start-up based in Powys. This equity investment, supported by an additional £185,000 from London-based SFC Capital, will enable Amped PCR to bring its innovative PurifAI system and Amped Universal reagent to a broader market.

PurifAI is a state-of-the-art DNA testing system designed to simplify and decentralise DNA diagnostics. The modular lab combines advanced automation and artificial intelligence, enabling faster, more efficient DNA testing outside traditional laboratory environments.

Transforming Industries with Real-Time DNA Testing

Amped PCR’s PurifAI system addresses critical challenges across industries, including food safety, environmental monitoring, and pathogen detection. Its on-site DNA testing capabilities empower industries to detect harmful pathogens like Salmonella and Listeria, helping mitigate risks and safeguard public health.

Founder Ben Davis brings over 15 years of experience in DNA diagnostics. “Our goal is to make DNA testing as intuitive as using a smartphone. PurifAI puts cutting-edge testing power into users’ hands, wherever they are and whatever their DNA question may be,” he explained.

Co-founder Aysha Shah, a product design and user experience specialist, emphasised the importance of usability: “By prioritising accessibility, we’re creating a tool that addresses global challenges while fitting seamlessly into existing workflows.”

Strategic Backing for a Promising Technology

The Development Bank of Wales provided funding through its Tech Seed Fund, which offers equity investments of up to £350,000 to innovative tech companies in Wales. Linzi Plant, assistant investment executive at the Development Bank, praised the collaboration:

“The potential applications of PurifAI are enormous. Supporting innovative Welsh companies like Amped PCR is what our Technology Seed Fund is all about.”

SFC Capital’s Adam Beveridge echoed this sentiment: “Amped PCR’s disruptive technology has the potential to transform sectors, and we’re excited to support their journey.”

Amped PCR is inviting stakeholders to join its early-access programme and experience the transformative potential of PurifAI firsthand. “We’re seeking partners who share our vision of a safer, more sustainable future,” said Ben Davis.